Overview
Mumps is an acute viral infection caused by the mumps virus, a member of the Paramyxoviridae family, which primarily affects the salivary glands, especially the parotid glands. The infection spreads through respiratory droplets and close personal contact. Serological testing for Mumps IgG and IgM antibodies is used to determine immune status, confirm recent infection, and support diagnosis when clinical features are suggestive. IgM antibodies indicate recent or active infection, while IgG antibodies reflect past exposure or immunity, either from previous infection or vaccination. Antibody testing plays an important role in epidemiological surveillance and in differentiating acute infection from prior immunity.
Symptoms
Mumps infection may present with mild or nonspecific symptoms initially, including fever, headache, malaise, muscle pain, and loss of appetite. A characteristic feature is painful swelling of one or both parotid glands, leading to facial swelling and tenderness near the jaw and ears. Some individuals may experience sore throat, difficulty chewing or swallowing, and ear pain. In certain cases, complications such as orchitis, oophoritis, meningitis, encephalitis, or pancreatitis may occur, particularly in adolescents and adults. Asymptomatic or subclinical infections are also common, making laboratory testing essential for confirmation.
Causes
Mumps is caused by infection with the mumps virus, which enters the body through the upper respiratory tract and spreads via the bloodstream to various organs. The immune system responds by producing specific antibodies. IgM antibodies generally appear early in the course of infection, usually within a few days after symptom onset, and persist for several weeks. IgG antibodies develop later and provide long-term immunity. Detection of these antibodies in serum helps determine whether the individual has a current infection, a past infection, or immunity due to vaccination.
Risk Factors
Individuals at increased risk include those who are unvaccinated or inadequately vaccinated, people living in crowded settings, and those with close contact to infected individuals. Children, adolescents, and young adults are commonly affected, although adults may experience more severe disease and complications. Immunocompromised individuals may show altered antibody responses, which can affect the interpretation of results. Timing of sample collection is critical, as early testing may yield negative results before antibody levels rise.
Prevention
Prevention of mumps relies primarily on immunization with the measles, mumps, and rubella vaccine, which provides effective long-term protection. Serological testing for IgG antibodies helps assess immune status in individuals with uncertain vaccination history or exposure risk. In suspected acute cases, timely IgM antibody testing supports early diagnosis and appropriate public health measures. Proper sample collection, correct timing of testing, and interpretation alongside clinical findings help reduce false-negative or false-positive results. Early identification and prevention strategies contribute to controlling outbreaks and reducing complications associated with mumps infection.
